C12Q 2521/00
Reaction characterised by the enzymatic activity
C12Q2521/00 (Reaction characterised by the enzymatic activity) appears on 471 US grants and 780 published applications in this corpus.
Search patents in C12Q- Granted patents
- 471
- Published applications
- 780
- Assignees
- 380
- Inventors
- 1,349
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 5 | 0 |
| 2001 | 4 | 0 |
| 2002 | 5 | 2 |
| 2003 | 3 | 6 |
| 2004 | 2 | 5 |
| 2005 | 1 | 4 |
| 2006 | 2 | 5 |
| 2007 | 1 | 1 |
| 2008 | 3 | 3 |
| 2009 | 0 | 3 |
| 2010 | 1 | 9 |
| 2011 | 2 | 13 |
| 2012 | 4 | 13 |
| 2013 | 7 | 12 |
| 2014 | 5 | 15 |
| 2015 | 13 | 20 |
| 2016 | 18 | 34 |
| 2017 | 17 | 40 |
| 2018 | 22 | 84 |
| 2019 | 27 | 79 |
| 2020 | 58 | 98 |
| 2021 | 46 | 83 |
| 2022 | 44 | 74 |
| 2023 | 48 | 42 |
| 2024 | 43 | 59 |
| 2025 | 50 | 43 |
| 2026 | 31 | 33 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- RNA sequencing method for the analysis of b and t cell transcriptome in phenotypically defined b and t cell subsets6 Oct 2026US 12,753,436 B2Centre National de la Recherche Scientifique (CNRS)
- Composition and methods related to modification of 5 hydroxymethylcytosine (5-hmC)6 Oct 2026US 12,753,445 B2The University of Chicago
- Methods and compositions for detecting a target RNA22 Sep 2026US 12,742,196 B2The Regents of the University of California
- Methods for RNA analysis8 Sep 2026US 12,729,395 B2CureVac Manufacturing GmbH
- Methods for genome assembly and haplotype phasing1 Sep 2026US 12,725,678 B2The Regents of the University of California
- Nucleic Acid Sequence Analysis from Single Cells8 Oct 2026US 2026/0308573 A1Illumina, Inc.
- Methods for rna analysis1 Oct 2026US 2026/0297648 A1CureVac AG
- Linked ligation1 Oct 2026US 2026/0297658 A1Ncan Genomics, Inc.
- Linked ligation1 Oct 2026US 2026/0297659 A1Ncan Genomics, Inc.
- Rna-guided nucleases and active fragments and variants thereof and methods of use3 Sep 2026US 2026/0258452 A1Life Edit Therapeutics, Inc.
Most cited
By later US patents
- Transposition of native chromatin for personal epigenomics255US 10,059,989 B2The Board of Trustees of the Leland Stanford Junior University · 2018
- Field-switch sequencing180US 7,462,452 B2Pacific Biosciences of California, Inc. · 2008
- DNA encoding a thermostable nucleic acid polymerase enzyme from thermotoga maritima164US 5,374,553 AHoffmann-La Roche Inc. · 1994
- Compositions and methods for molecular labeling141US 9,150,852 B2Raindance Technologies, Inc. · 2015
- Method for relative quantification of nucleic acid sequence, expression, or copy changes, using combined nuclease, ligation, and polymerase reactions130US 9,598,728 B2Cornell University · 2017